Data as of Dec 24
| +0.44 / +1.31%|
The 8 analysts offering 12-month price forecasts for Wuxi Pharmatech Cayman Inc have a median target of 41.50, with a high estimate of 47.00 and a low estimate of 30.00. The median estimate represents a +21.56% increase from the last price of 34.14.
The current consensus among 10 polled investment analysts is to Buy stock in Wuxi Pharmatech Cayman Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.